+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Intensity Modulated Radiation Therapy for Gastric Diffuse Large B-Cell Lymphoma in the Rituximab Era: Dosimetric Analysis, Clinical Outcome, and Long-term Quality of Life



Intensity Modulated Radiation Therapy for Gastric Diffuse Large B-Cell Lymphoma in the Rituximab Era: Dosimetric Analysis, Clinical Outcome, and Long-term Quality of Life



International Journal of Radiation Oncology*biology*physics 93(3): E453-E454




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 064699341

Download citation: RISBibTeXText

DOI: 10.1016/j.ijrobp.2015.07.1704


Related references

Intensity Modulated Radiation Therapy for Early-Stage Primary Gastric Diffuse Large B-Cell Lymphoma: Dosimetric Analysis, Clinical Outcome, and Quality of Life. International Journal of Radiation Oncology, Biology, Physics 95(2): 712-720, 2017

Dosimetric and Clinical Outcomes With Intensity Modulated Radiation Therapy After Chemotherapy for Patients With Early-Stage Diffuse Large B-cell Lymphoma of Waldeyer Ring. International Journal of Radiation Oncology, Biology, Physics 96(2): 379-386, 2017

High-dose and extended-field intensity modulated radiation therapy for early-stage NK/T-cell lymphoma of Waldeyer's ring: dosimetric analysis and clinical outcome. International Journal of Radiation Oncology, Biology, Physics 87(5): 1086-1093, 2014

Long-term outcome of diffuse large B-cell lymphoma: Impact of biosimilar rituximab and radiation. Indian Journal of Cancer 54(2): 430-435, 2018

Dosimetric evaluation and treatment outcome of intensity modulated radiation therapy after doxorubicin-based chemotherapy for primary mediastinal large B-cell lymphoma. International Journal of Radiation Oncology, Biology, Physics 85(5): 1289-1295, 2013

Intensity-modulated radiation therapy in the treatment of gastric cancer: early clinical outcome and dosimetric comparison with conventional techniques. British Journal of Radiology 79(942): 497-503, 2006

Dosimetric Analysis and Clinical Outcome of Prophylactic Intensity Modulated Radiation Therapy in pT3N0M0R0 Esophageal cancer. International Journal of Radiation Oncology*biology*physics 90(1): S345-S346, 2014

Long-term clinical outcome of intensity-modulated radiation therapy for locally advanced esophageal squamous cell carcinoma. Tumori 101(2): 168-173, 2015

Long-term follow-up of localized, primary gastric diffuse large B-cell lymphoma treated with rituximab and CHOP. Experimental and Therapeutic Medicine 3(2): 304-308, 2012

Clinical Outcome of Rituximab-Based Therapy (RCHOP) in Diffuse Large B-Cell Lymphoma Patients with Bone Marrow Involvement. Cancer Research and Treatment 45(2): 112-117, 2013

Role of radiation therapy in primary breast diffuse large B-cell lymphoma in the Rituximab era: a SEER database analysis. Cancer Medicine 7(5): 1845-1851, 2018

Hitting a Moving Target: Successful Management of Diffuse Large B-cell Lymphoma Involving the Mesentery With Volumetric Image-guided Intensity Modulated Radiation Therapy. Clinical Lymphoma, Myeloma and Leukemia 2018, 2018

Poster Combined Modality Therapy for Stage l-ll Diffuse Large B-cell Lymphoma Provides Excellent Local Control and Clinical Outcome in the Rituximab Era. European Journal of Cancer 47: S644-S645, 2011

SU-E-T-550: Influence of the Clinical Outcome and Quality of Life by Replanning during Intensity-Modulated Radiation Therapy for Nasopharyngeal Carcinoma. Medical Physics 39(6part18): 3832, 2012

Analysis of clinical characteristics and outcome of patients with previously untreated diffuse large B-cell lymphoma and renal involvement in the rituximab era. Leukemia and Lymphoma 57(11): 2619-2625, 2017